Furthermore, it was found that tumors with high levels of CD8-positive tumor-infiltrating lymphocytes (TILs) demonstrated a more favorable prognosis compared to those with low levels, even among tumors with abnormal p53 expression (trend for OS and significant difference for DFS) [82]. The gene discussed is CD8A; the disease is neoplasm.